Arkolith/Insider Trading/TARA/Form 4

Shefferman Jesse

CEO and President, DirectorProtara Therapeutics, Inc. (TARA) · full profile →Form 4 · filed Jul 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$882K
Net Open-Market Flow
-$882K
Transactions
7
6 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2026Gift(G)7K—$0701K
Jun 30, 2026Gift(G)14K—$0708K
Jun 30, 2026Gift(G)4K—$0697K
Jun 30, 2026Gift(G)5K—$0692K
Jun 29, 2026Sell(S)216K$4.09$882K722K
Jun 29, 2026Option exercise(M)216K$1.91$412K938K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)216K—$0141K

Transaction Codes

G
Gift
S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-074238) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML